For enhancing the efficacy of cystic fibrosis gene therapy, AdVs with promoters specific to airway cells have been developed, such as the 2 kb 5′-untranslated DNA sequences of the CFTR gene [75] and the k18 promoter—an epithelial cell expression cassette of keratin 18 [76]. Here, KRT18 is linked to cystic fibrosis.